Table 2.

Age at appearance of signs and start of different treatments

Patients	Age	Age at appearance of signs and start of different treatments
Case # 1 N.NE	47 days	Signs appeared
	52 days	Came to hospital with DKA; treatment: low-dose insulin infusion, fluid therapy, then maintenance insulin therapy
	58 days	Glibenclamide
	2.4 years	Repaglinide
	10 years	Repaglinide; no adverse events
Case # 2 I.M.	3 months and 5 days	Signs appeared
	3 months and 15 days	Came to hospital with DKA; low-dose insulin infusion, fluid therapy, then maintenance insulin therapy
	3 months and 20 days	Glibenclamide
	4 months and 20 days	Repaglinide
	9 years	Repaglinide; no adverse events

DKA diabetic ketoacidosis